×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
导航切换
Journal of International Oncology
Home
About Journal
About Journal
Journal History
Objective
Editorial Committee
Editorial Boards
Communications Editorial Board
Introduction to Editor-in-Chief
General Principles of the Editorial Board
Guide for Authors
Online Submission Guide
Instructions for Authors
Publication Ethics
Aim and Scope
Subscribe
Contacts Us
中文
Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei
Journal of International Oncology . 2021, (
7
): 409 -414 . DOI: 10.3760/cma.j.cn371439-20201026-00078
